InsidersTradesSigma
Browse the detailed record of transactions filed by Tulipano Stephen J, Chief Financial Officer. Insider active across 1 companies, notably Stoke Therapeutics, Inc.. Cumulatively, 1 disclosures have been published. The latest transaction was filed on 2 June 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration
Stephen J. Tulipano is the CFO at Stoke Therapeutics, Inc. He oversees the financial management of the company, including budgeting and financial performance analysis. His role is crucial in ensuring Stoke's financial health and supporting its growth initiatives.